Skip to main content
Premium Trial:

Request an Annual Quote

Pacific Biosciences, Radboud University Partner to Study Clinical Use of Long-Read Sequencing

NEW YORK – Pacific Biosciences and Radboud University Medical Center said on Wednesday that they have partnered to evaluate long-read, whole-genome sequencing (WGS) as a first-line clinical assay for rare disease.

Under the terms of the deal, they will study the genetic causes of rare disease as well as the feasibility and cost effectiveness of using PacBio's HiFi sequencing technology as part of routine clinical use.

"We believe the recent advances in throughput and cost brought by the Revio sequencing system will enable Radboud UMC to test thousands of samples by long-read WGS all within a single center," Alexander Hoischen, associate professor of genomic technologies and immunogenomics at the center, said in a statement. "This will allow us to study the potential clinical utility and better understand the health economics of bringing highly accurate HiFi sequencing in a clinical setting on a large scale."

PacBio said it will both donate reagents and provide discounted consumables, as well as workflow and bioinformatics expertise.

Other details of the partnership were not disclosed.

The partnership adds to PacBio's collection of efforts using long-read sequencing to study and diagnose rare disease. The firm also has projects going with the Rady Children's; the University of California, Los Angeles; Boston Children's Hospital, Children's Mercy Hospital, and the Care4Rare Canada Consortium.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.